Tyrvaya Spray
Product Images NDC 73521-030

Product Visual Gallery

This gallery contains 17 technical images submitted to the FDA as part of the official labeling for Tyrvaya (NDC 73521-030). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Oyster Point Pharma, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

The Chemical Structure (Varenicline 01)

Chemical structure diagram showing the molecular structures of varenicline and another compound, likely representing ingredients or related chemical entities in the Tyrvaya nasal spray formulation.*

FDA Label Image

Tyrvaya Nasal Spray (Varenicline 02)

An illustration diagram showing components of the Tyrvaya nasal spray including the nasal applicator, base of the nasal applicator, bottle, cap, and clip. The parts are labeled and displayed separately for clarity.*

FDA Label Image

Remove Clip/cap (Varenicline 03)

An instructional illustration showing two steps for preparing a nasal spray. The left side depicts a hand removing the spray bottle cap, and the right side shows a hand removing a clip from the spray nozzle.*

FDA Label Image

Step 2. Hold The Nasal Spray Upright And Away From Your Face. Place One Finger On Each Side Of The Base Of The Nasal Applicator, And Place Your Thumb Underneath The Bottle. (Varenicline 04)

An instructional line drawing showing a person holding a nasal spray bottle, positioned near the nose, illustrating the use of Tyrvaya nasal spray (varenicline). The image demonstrates the proper method to administer the nasal spray via the nasal route.*

FDA Label Image

Press 7 Times (Varenicline 05)

An instructional illustration showing a hand holding a nasal spray bottle labeled Tyrvaya (varenicline). The image indicates pressing the spray nozzle 7 times with an arrow pointing upward to demonstrate priming or preparing the spray for use.*

FDA Label Image

Step 1. Blow Nose To Clear Nostrils If Needed. (Varenicline 06)

An instructional illustration depicts a person administering a nasal spray by holding the spray device near the nostril and pressing it to deliver the medication, demonstrating proper use of a nasal spray product.*

FDA Label Image

Remove Cap/clip (Varenicline 07)

Instructional illustration showing a two-step process for preparing Tyrvaya nasal spray. The left panel demonstrates removing the cap from the spray bottle, and the right panel shows removing the clip from the nozzle. Both steps are depicted with hands manipulating the spray container.*

FDA Label Image

Step 3. Hold The Nasal Spray Upright. Place One Finger On Each Side Of The Base Of The Nasal Applicator And Your Thumb Underneath The Bottle. (Varenicline 08)

An instructional illustration showing a hand holding a small nasal spray bottle upright with the index finger pressing down on the pump. The nasal spray is identified as Tyrvaya (varenicline) nasal spray, 0.03 mg per 0.05 mL, used for human prescription.*

FDA Label Image

Step 4. Tilt Your Head Back Slightly. (Varenicline 09)

An instructional illustration showing a woman tilting her head backward while keeping the neck straight, with an arrow indicating the head should be tilted upward. Next to it, a circular symbol with a slash indicates that tilting the head backward with the neck bent is not recommended.*

FDA Label Image

Step 5. Insert The Nasal Applicator Into The Left Or Right Nostril. Tilt The Nasal Applicator And Aim The Tip Towards The Top Of The Ear On The Same Side. Do Not Press The Tip Of Nasal Applicator Against The Wall Of The Inside Of Your Nose. Allow For A Space Between The Tip Of Nasal Applicator And The Wall Of The Inside Of Your Nose For Proper Dose Administration. (Varenicline 0a)

Instructional illustration showing nasal spray use. On the left, a person tilts their head back slightly and inserts the spray nozzle into one nostril. On the right, a close-up diagram depicts the spray nozzle with an arrow indicating to leave space between the nozzle tip and the nostril opening.*

FDA Label Image

Step 6. Place Tongue To The Roof Of The Mouth And Breathe Gently While Spraying 1 (one) Time. Repeat Administration In The Other Nostril. Wait 2 (two) Or 3 (three) Minutes Before Blowing Nose If Needed. (Varenicline 0b)

Illustration showing a person using a nasal spray, instructing to breathe gently while spraying once into the nose. Arrows indicate the direction of the spray application.*

FDA Label Image

Step 7. Wipe The Nasal Applicator With A Clean Tissue. (Varenicline 0c)

An instructional illustration showing a hand opening a clear glass vial, with the other hand holding the vial steady. The image appears to guide on how to access the vial, likely related to the use of Tyrvaya nasal spray.*

FDA Label Image

Step 8. Replace Clip And Cap. (Varenicline 0d)

Instructional illustration showing how to replace the clip and cap on a nasal spray bottle. The left panel depicts removing and replacing the clip on the spray bottle, and the right panel shows how to replace the cap by pushing it down onto the bottle.*

FDA Label Image

Diagramdescription Automatically Generated (Varenicline 0e)

Tyrvaya (varenicline solution) nasal spray 0.03 mg packaging label for intranasal use. The label highlights the spray strength of 0.03 mg per 0.05 mL, includes details for two nasal spray bottles designed for a 30-day supply, each containing 60 sprays. The label also shows storage instructions, warnings against eye use, and manufacturer Oyster Point Pharma, Inc., Princeton, NJ.*

FDA Label Image

Textdescription Automatically Generated (Varenicline 0f)

Tyrvaya nasal spray label showing 0.03 mg varenicline per 0.05 mL strength with 60 sprays, net content 4.2 mL. The label indicates the product is for intranasal use, manufactured by Oyster Point Pharma, Inc., with storage instructions and usage guidelines.*

FDA Label Image

Diagramdescription Automatically Generated (Varenicline 10)

Tyrvaya nasal spray 0.03 mg (varenicline solution) label for a prescription human drug by Oyster Point Pharma, Inc. The label includes instructions to prime before first use and for intranasal use only. It shows a 15-day supply with 60 sprays in one bottle, storage instructions, and warnings. The label features the Tyrvaya logo and dosage information prominently on the front and side panels.*

FDA Label Image

Graphical User Interface, Text, Applicationdescription Automatically Generated With Medium Confidence (Varenicline 11)

Tyrvaya nasal spray 0.03 mg/0.05 mL label by Oyster Point Pharma, Inc. The label indicates each 50 µL spray contains varenicline 0.03 mg, with 60 sprays per bottle (4.2 mL net content). It states intranasal use, to prime before first use, and marks the product as a sample not for sale. Storage instructions specify 20°C to 25°C (68°F to 77°F) and not freezing, with discard 30 days after first use.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.